Yield10 Bioscience Inc (YTENQ)

Yield10 Bioscience Inc is a U.S.-listed common stock on OTC Markets associated with an agricultural bioscience company focused on commercializing Camelina oilseed-based products. Its business has centered on Camelina oil applications for omega-3 fatty acid production, including EPA and DHA, as well as low-carbon feedstock uses for biofuels such as biodiesel, renewable diesel, and sustainable aviation fuel. The company was incorporated in 1992 and is headquartered in Woburn, Massachusetts. Formerly known as Metabolix, Inc., it adopted the Yield10 Bioscience name in January 2017. On December 6, 2024, the company and certain affiliates filed voluntary Chapter 11 reorganization petitions in the U.S. Bankruptcy Court for the District of Delaware, and the plan was later approved as Chapter 11 liquidation on October 14, 2025.

Jump directly to the stock analysis sections supported by the latest available data.